BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| EC330 | EC330 is a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range, blocked formation of colonies in soft agar and inhibited angiogenesis (tube formation) in HUVEC cells. EC330 as a novel LIF inhibitor has targeted therapeutic perspectives for patients with aggressive primary tumors. Group: Pharmaceutical. Alternative Names: EC330; EC 330; EC-330; (8S,11R,13S,14S,17S)-11-(4-cyclopropylphenyl)-17-(1,1-difluoroprop-2-ynyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one. CAS No. 2016795-77-8. Pack Sizes: 5 mg. Product ID: B0084-007323. Molecular formula: C30H32F2O2. Mole weight: 462.57. Custom synthesis is available. Send your inquiries for more information. |  London |
| Ecamsule.2Na | Ecamsule protect the skin from sunburn and erythema. It causes serious eye damage, so please wear protective gloves/protective clothing/eye protection/face protection. Uses: Sunscreening agents. Group: Pharmaceutical. Alternative Names: Sodium ((1,4-phenylenebis(methanylylidene))bis(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl-3-ylidene))dimethanesulfonate. CAS No. 90458-75-6. Pack Sizes: 10 g. Product ID: B0001-473967. Molecular formula: C28H32Na2O8S2. Mole weight: 606.66. Custom synthesis is available. Send your inquiries for more information. | London |
| Ecdysterone 20,22-monoacetonide | Ecdysterone 20,22-monoacetonide isolated from the roots of Cyanotis arachnoidea C. B. Clarke. Group: Pharmaceutical. Alternative Names: 20-hydroxyecdysone 20,22-acetonide; (2β,3β,5β,17β)-2,3,14-Trihydroxy-17-[(4R,5R)-5-(3-hydroxy-3-methy lbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]androst-7-en-6-one. CAS No. 22798-96-5. Pack Sizes: 1 mg. Product ID: NP6159. Molecular formula: C30H48O7. Mole weight: 520.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Ecdysterone 2,3:20,22-diacetonide | Ecdysterone 2,3:20,22-diacetonide isolated from the roots of Cyanotis arachnoidea C. B. Clarke. Group: Pharmaceutical. Alternative Names: 20-hydroxy-23,24-dinor-chol-4-en-3-one. CAS No. 22798-98-7. Pack Sizes: 1 mg. Product ID: NP6157. Molecular formula: C33H52O7. Mole weight: 560.8. Custom synthesis is available. Send your inquiries for more information. | London |
| Echinacoside | Echinacoside, a natural polyphenolic compound, has various kinds of pharmacological activities, such as antioxidative, anti-inflammatory, neuroprotective, hepatoprotective, nitric oxide radical-scavenging and vasodilative ones. Group: Pharmaceutical. Alternative Names: 2-(3,4-Dihydroxyphenyl)ethyl 4-(3-(3,4-dihydroxyphenyl)-2-propenoate)-3-O-(b-D-glucopyranose)-6-O-(a-L-rhamnopyranose)-b-D-glucopyranoside. CAS No. 82854-37-3. Pack Sizes: 25 mg. Product ID: NP5238. Molecular formula: C35H46O20. Mole weight: 786.74. Custom synthesis is available. Send your inquiries for more information. | London |
| ECHINULIN | Echinulin is isolated from Aspergillus chevalieri. Group: Pharmaceutical. Alternative Names: (3S,6S)-3-[[2-(1,1-Dimethyl-2-propenyl)-5,7-bis(3-methyl-2-butenyl)-1H-indol-3-yl]methyl]-6-methyl-2,5-piperazinedione; Echinuline. CAS No. 1859-87-6. Pack Sizes: 1 mg. Product ID: BBF-04134. Molecular formula: C29H39N3O2. Mole weight: 461.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Echitamine | Echitamine, a natural indole alkaloid found in the herbs of Alstonia scholaris, exhibits the activity of anti-tumour activity in-vitro and in-vivo. Uses: Anti-tumour. Group: Pharmaceutical. Alternative Names: (16R)-3β,17-Dihydroxy-16-(methoxycarbonyl)-4-methyl-2,4(1H)-cyclo-3,4-secoakuammilan-4-ium. CAS No. 6871-44-9. Pack Sizes: 1 mg. Product ID: NP0321. Molecular formula: C22H29N2O4. Mole weight: 385.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Echitovenidine | Echitovenidine is an alkaloid isolated from the fruits of Alstonia venenata. In vitro and in vivo studies revealed that echitovenidine has an inhibitory effect on monoamine oxidase. Group: Pharmaceutical. Alternative Names: Aspidospermidine-3-carboxylic acid, 2,3-didehydro-20-((3-methyl-1-oxo-2-butenyl)oxy)-, methyl ester, (5-alpha,12-beta,19-alpha,20R)-. CAS No. 7222-35-7. Pack Sizes: 1 mg. Product ID: NP0753. Molecular formula: C26H32N2O4. Mole weight: 436.552. Custom synthesis is available. Send your inquiries for more information. | London |
| Echitoveniline | Echitoveniline is an alkaloid isolated from the fruits and leaves of Alstonia venenata R.Br. Group: Pharmaceutical. Alternative Names: Echitoveniline; 72855-79-9; HY-N9161; AKOS040761655; CS-0158870; methyl (1R,12R,19R)-12-[(1R)-1-(3,4,5-trimethoxybenzoyl)oxyethyl]-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9-tetraene-10-carboxylate. CAS No. 72855-79-9. Pack Sizes: 1 mg. Product ID: NP0759. Molecular formula: C31H36N2O7. Mole weight: 548.636. Custom synthesis is available. Send your inquiries for more information. | London |
| Econazolum | Econazole, structurally similar to miconazole, is an effective antifungal drug. Group: Pharmaceutical. Alternative Names: 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; Econazole; Econazole Nitrate; Ekonazole; Gyno Pervaryl 150; Gyno Pevaril; Gyno Pevaryl; Gyno-Pervaryl 150; Gyno-Pevaril; Gyno-Pevaryl; GynoPevaril;Nitrate, Econazole; Pevaryl. CAS No. 27220-47-9. Pack Sizes: 1mg;1g;10g. Product ID: 27220-47-9. Molecular formula: C18H15Cl3N2O. Mole weight: 381.68. Custom synthesis is available. Send your inquiries for more information. | London |
| (E)-Crotylbarbital | (E)-Crotylbarbital is the isomer of Crotylbarbital which is a barbiturate derivative with sedative and hypnotic properties. Group: Pharmaceutical. Alternative Names: 5-[(E)-but-2-enyl]-5-ethyl-1,3-diazinane-2,4,6-trione; 5-ethyl-5-crotylbarbituric acid; calypnon; crotarbital; crotarbital, (E)-isomer; crotarbital, sodium salt; crotylbarbital; krotylbarbital. CAS No. 28360-89-6. Pack Sizes: 1mg;1g;10g. Product ID: 28360-89-6. Molecular formula: C10H14N2O3. Mole weight: 210.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Ectoine | Ectoine is derived from high halophage bacteria, so it is also called salt-tolerant bacteria extract. Ectoine is an amino acid derivative and belongs to the extreme enzyme component. It has a strong water molecule capture, complexation ability, and can structure the free water in the cell. It has a powerful cell repair and anti-inflammatory repair function. It can increase the cell repair ability, repair the cell DNA damage caused by ultraviolet light, and have a good repair effect on the light damage caused by ultraviolet light. Group: Pharmaceutical. Alternative Names: L-Ectoine; (S)-2-Methyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid; (S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid; (4S)-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid. CAS No. 96702-03-3. Pack Sizes: 25 g. Product ID: BBF-04195. Molecular formula: C6H10N2O2. Mole weight: 142.16. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone | Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibites apoptosis, and blocks nonenzymatic peroxidation and lipoxygenase activity. Group: Pharmaceutical. Alternative Names: Edaravone; MCI-186; MCI 186; MCI186; Radicut; Arone. CAS No. 89-25-8. Pack Sizes: 1mg;1g;10g. Product ID: NP3392. Molecular formula: C10H10N2O. Mole weight: 174.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone-[d5] | Edaravone-[d5] is a deuterium labelled form of Edaravone. Edaravone is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis. Group: Pharmaceutical. Alternative Names: 2,4-Dihydro-5-methyl-2-(phenyl-2,3,4,5,6-d5)-3H-pyrazol-3-one; Edaravone D5. CAS No. 1228765-67-0. Pack Sizes: 100 mg. Product ID: BLP-005273. Molecular formula: C10H5D5N2O. Mole weight: 179.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone Impurity III | Edaravone Impurity. Group: Pharmaceutical. Alternative Names: 2-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-2-sulfopropanoic acid; 2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-sulfopropanoic acid; Edaravone Impurity III; Edaravone IMpurity P1; DTXSID80855974; BCP18301; AC-30014; B0060-462129; 2-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-2-sulfopropanoicacid. CAS No. 1357477-99-6. Pack Sizes: 5 mg. Product ID: B0060-462129. Molecular formula: C13H14N2O6S. Mole weight: 326.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone impurity P3 | Edaravone Impurity. Group: Pharmaceutical. Alternative Names: Edaravone Impurity VI. CAS No. 1323485-71-7. Pack Sizes: 10 mg. Product ID: B0060-462130. Molecular formula: C13H16N2O4S. Mole weight: 296.35. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone Impurity V | An impurity of Edaravone, a medication for the recovery from stroke. Group: Pharmaceutical. Alternative Names: 4,4-Bis(1-phenyl-3-methyl-5-oxo-3-pyrazoline-4-yl)-1-phenyl-3-methyl-1H-pyrazole-5(4H)-one. CAS No. 124009-63-8. Pack Sizes: 100 mg. Product ID: B0060-470643. Molecular formula: C30H26N6O3. Mole weight: 518.577. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone Trimer | Edaravone Trimer is an impurity of Edaravone. Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibits apoptosis, and blocks nonenzymatic peroxidation and lipoxygenase activity. Group: Pharmaceutical. Alternative Names: 5,?5',?5''-trimethyl-2,?2',?2''-triphenyl-[4,?4':4',?4''-Ter-4H-pyrazole]?-3,?3',?3''(2H,?2'H,?2''H)?-trione; 4,4-bis(3-methyl-5-oxo-1-phenyl(2-pyrazolin-4-yl))-3-methyl-1-phenyl-2-pyrazol in-5-one; 2-Phenyl-5-methyl-4,4-bis(2-phenyl-3-oxo-5-methyl-3,4-dihydro-2H-pyrazole-4-yl)-3,4-dihydro-2H-pyrazole-3-one. CAS No. 68195-63-1. Pack Sizes: 50 mg. Product ID: B1370-105475. Molecular formula: C30H26N6O3. Mole weight: 518.58. Custom synthesis is available. Send your inquiries for more information. | London |
| Edetate trisodium | Edetate trisodium, a chelating agent that sequesters and decreases the reactivity of metal ions, is used to treat mercury and lead poisoning. Group: Pharmaceutical. Alternative Names: trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate; Edetate trisodium; edta trisodium; Trisodium edetate; Trisodium ethylenediaminetetraacetate; Ethylenediaminetetraacetic acid trisodium salt; 150-38-9; EDTA trisodium salt; UNII-420IP9. CAS No. 150-38-9. Pack Sizes: 1mg;1g;10g. Product ID: 150-38-9. Molecular formula: C10H13N2Na3O8. Mole weight: 358.19. Custom synthesis is available. Send your inquiries for more information. | London |
| Edonerpic maleate | The maleate salt form of Edonerpic, which is a neuroproptectant. Edonerpic is in clinical trials for the treatment of Alzheimer's disease (AD). It inhibits oxidative stress and nitric oxide-induced neurotoxicity and acts as a neurotrophic factor, as well as it may be beneficial for the treatment of neurodegenerative disorders related to oxidative stress, such as Parkinson's disease. Uses: Candidate therapeutic agent for alzheimer's disease. Group: Pharmaceutical. Alternative Names: T-817 maleate; T-817MA; 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol maleate. CAS No. 519187-97-4. Pack Sizes: 10 mg. Product ID: B0084-054035. Molecular formula: C20H25NO6S. Mole weight: 407.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Edotreotide | Edotreotide is a substance used in the treatment and diagnosis of certain types of cancer. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; (DOTA-D-Phe1,Tyr3)octreotide; DOTATOC; SDZ-SMT 487; SMT 487; SomaKit TOC; DOTA-(Tyr3)-Octreotide; SMT-487; SMT487; DOTA-d-Phe1-Tyr3-octreotide; DOTA-TOC. CAS No. 204318-14-9. Pack Sizes: 1 mg. Product ID: BAT-010135. Molecular formula: C65H92N14O18S2. Mole weight: 1421.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity G tosylate | An impurity of Edoxaban, an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide 4-methylbenzenesulfonate; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, compd. with 4-methylbenzenesulfonate (1:1); N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide tosylate. CAS No. 2852734-47-3. Pack Sizes: 2 mg. Product ID: B1370-448091. Molecular formula: C31H38ClN7O7S2. Mole weight: 720.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity H | Edoxaban Impurity. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-[(1S,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide. CAS No. 1255529-28-2. Pack Sizes: 2.5 mg. Product ID: B2694-470647. Molecular formula: C24H30ClN7O4S. Mole weight: 548.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity I | The enantiomer of Edoxaban, Edoxaban Impurity. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide. CAS No. 1255529-23-7. Pack Sizes: 2.5 mg. Product ID: B2694-470648. Molecular formula: C24H30ClN7O4S. Mole weight: 548.07. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban N-Oxide | An impurity of Edoxaban, which is an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: (5S)-5-Oxide Edoxaban; 2-(((1R,2S,5S)-2-(2-((5-Chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-Oxide. CAS No. 2244103-96-4. Pack Sizes: 50 mg. Product ID: B1370-377836. Molecular formula: C24H30ClN7O5S. Mole weight: 564.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban Oxoacetic Acid Impurity | An impurity of Edoxaban, which is an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: Edoxaban metabolite M1; Edoxaban M1 Impurity; 4S-Des-3-chloropyridine Edoxaban. CAS No. 767625-11-6. Pack Sizes: 100 mg. Product ID: B1370-377833. Molecular formula: C19H27N5O5S. Mole weight: 437.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban Tosylate Hydrate | In human plasma, Edoxaban doubles prothrombin time and activates partial thromboplastin time at 0.256 and 0.508 μM, respectively. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-Toluenesulfonate hydrate; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide mono(p-toluenesulfonate) hydrate; Edoxaban p-toluenesulfonate monohydrate. CAS No. 1229194-11-9. Pack Sizes: 1 g. Product ID: B0084-463378. Molecular formula: C24H30ClN7O4S.C7H8O3S.H2O. Mole weight: 738.27. Custom synthesis is available. Send your inquiries for more information. | London |
| EED-226 | EED-226 is a novel allosteric Polycomb repressive complex 2 (PRC2) inhibitor (IC50 = 23.4 nM when the substrate is H3K27me0 peptide and IC50 = 53.5 nM when the substrate is mononucleosom). EED-226 induces a conformational change via binding EED which invalidates PRC2 activity. PRC2 plays pivotal roles in transcriptional regulation. EED-226 has the potential to treat PRC2-dependent cancers, such as human lymphoma xenograft tumors. Group: Pharmaceutical. Alternative Names: EED226; EED-226; EED 226. N-(2-furanylmethyl)-8-[4-(methylsulfonyl)phenyl]-1,2,4-triazolo[4,3-c]pyrimidin-5-amine. CAS No. 2083627-02-3. Pack Sizes: 10 mg. Product ID: B0084-484681. Molecular formula: C17H15N5O3S. Mole weight: 369.4. Custom synthesis is available. Send your inquiries for more information. | London |
| EF-24 | EF-24. Group: Pharmaceutical. Alternative Names: EF 24; EF24; 3,5-bis((E)-2-fluorobenzylidene)piperidin-4-one hydrochloride. CAS No. 342808-40-6. Pack Sizes: 100 mg. Product ID: B1370-188713. Molecular formula: C19H16ClF2NO. Mole weight: 347.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Efavirenz aminoalcohol | An intermediate in the preparation of Efavirenz. Efavirenz is an antiretroviral medication used for the treatment of HIV/AIDS. Group: Pharmaceutical. Alternative Names: (S)-2-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluoro-3-butyn-2-ol; (αS)-2-Amino-5-chloro-α-(2-cyclopropylethynyl)-α-(trifluoromethyl)benzenemethanol; 1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol. CAS No. 209414-27-7. Pack Sizes: 1mg;1g;10g. Product ID: NP2681. Molecular formula: C13H11ClF3NO. Mole weight: 289.69. Custom synthesis is available. Send your inquiries for more information. | London |
| Effusol | Effusol is a metabolite of Dihydrophenanthrene that is found in the Juncus effusus L. Effusol. It exhibits antitumor activity. Group: Pharmaceutical. Alternative Names: 5-ethenyl-1-methyl-9,10-dihydrophenanthrene-2,7-diol; 1-methyl-5-vinyl-9,10-dihydrophenanthrene-2,7-diol. CAS No. 73166-28-6. Pack Sizes: 5 mg. Product ID: NP5261. Molecular formula: C17H16O2. Mole weight: 252.313. Custom synthesis is available. Send your inquiries for more information. | London |
| Effususol A | Effususol A is a natural compound used in the research of various types of cancer. With its unique chemical composition, this product has shown promising results in inhibiting the growth and proliferation of tumor cells. Group: Pharmaceutical. CAS No. 1869082-58-5. Pack Sizes: 1 mg. Product ID: NP5006. Molecular formula: C18H20O3. Mole weight: 284.355. Custom synthesis is available. Send your inquiries for more information. | London |
| Efinaconazole | Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes. Efinaconazole has been shown to be active against isolates of the following microorganisms, both in vitro and in clinical infections. Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0.06 μg/mL or less against most ( ≥ 90%) isolates of the following microorganisms: Trichophyton rubrum; Trichophyton mentagrophytes. Group: Pharmaceutical. Alternative Names: KP103; KP-103; KP 103; CTK5J2975; AGJ95634; KB145948; AGJ 95634; KB 145948; AGJ-95634; KB-145948; Efinaconazole; trade name: Jublia. CAS No. 164650-44-6. Pack Sizes: 50 mg. Product ID: B0084-463563. Molecular formula: C18H22F2N4O. Mole weight: 348.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Efinaconazole Related Impurity 3 | The S,S-enantiomer of Efinaconazole, a medication used to treat toenail infection caused by fungus. Group: Pharmaceutical. Alternative Names: ent-Efinaconazole; (2S,3S)-Efinaconazole; (αS,βS)-α-(2,4-Difluorophenyl)-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidine ethanol; [S-(R*,R*)]-α-(2,4-Difluorophenyl)-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidine ethanol. CAS No. 164650-45-7. Pack Sizes: 100 mg. Product ID: B2694-470719. Molecular formula: C18H22F2N4O. Mole weight: 348.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Efinaconazole Related Impurity 4 | An enantiomer of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Group: Pharmaceutical. Alternative Names: Efinaconazole 2S,3R Epoxy triazole; 1-(((2S,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole; 1-{[(2S,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole; (2S,3R)-2-(2,4-difluorophenyl)-3-methyl-2-(1H-1,2,4-triazol-1-yl)methyloxirane. CAS No. 135270-07-4. Pack Sizes: 5 mg. Product ID: B0821-470720. Molecular formula: C12H11F2N3O. Mole weight: 251.24. Custom synthesis is available. Send your inquiries for more information. | London |
| Eflornithine hydrochloride, hydrate | Eflornithine hydrochloride, hydrate is a drug found to be effective in the treatment of facial hirsutism. It is a "suicide inhibitor," irreversibly binding to Ornithine Decarboxylase (ODC) and preventing the natural substrate ornithine from accessing the active site. It is an irreversible inhibitor of ornithine decarboxylase that suppresses polyamine biosynthesis. It displays antiangiogenic and cytostatic effects in tumor cells but must be used in combination with other chemotherapeutic agents to negate compensatory increases in polyamine content through alternate synthesis pathways. It also demonstrates antiparasitic activity in a model of C. parvum infection. Group: Pharmaceutical. Alternative Names: DFMO hydrochloride hydrate; MDL-71782 hydrochloride hydrate; RMI-71782 hydrochloride hydrate; MDL 71782 hydrochloride hydrate; RMI 71782 hydrochloride hydrate; MDL71782 hydrochloride hydrate; RMI71782 hydrochloride hydrate; α-difluoromethylornithine hydrochloride hydrate; Vaniqa hydrochloride hydrate. CAS No. 96020-91-6. Pack Sizes: 10 g. Product ID: BAT-008153. Molecular formula: C6H15ClF2N2O3. Mole weight: 236.64. Custom synthesis is available. Send your inquiries for more information. | London |
| eFT-508 | eFT-508 is a selective inhibitor of MNK1/2 (IC50s = 2.4 nM and 1 nM respectively) inhibiting MNK1/2-mediated signaling and the phosphorylation of certain regulatory proteins. It acts against tumor. Group: Pharmaceutical. Alternative Names: SCHEMBL17362622; AKOS030627405; ZINC575623807; CS-5841; CS 5841; CS5841; 6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione; eFT508. CAS No. 1849590-01-7. Pack Sizes: 100 mg. Product ID: B0084-008131. Molecular formula: C17H20N6O2. Mole weight: 340.38. Custom synthesis is available. Send your inquiries for more information. | London |
| EGF816 | EGF816, also called as Nazartinib, a covalent mutant-selective EGFR inhibitor and potently inhibits the T790M resistance mutation while sparing wild-type EGFR. in vivo: demonstrated strong tumor regressions in several EGFR activating and resistant tumor m. Group: Pharmaceutical. Alternative Names: EGF816; EGF-816; EGF 816; NVS-816; NVS 816; NVS816; Nazartinib; N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamideEGF816UNII-KE7K32EME8KE7K32EME8EGF-8161508250-71-2GTPL9204SCHEMBL16767232SCHEMBL16767240EGF 816compound 47 [PMID: 27433829]. CAS No. 1508250-71-2. Pack Sizes: 10 mg. Product ID: B0084-474599. Molecular formula: C26H31ClN6O2. Mole weight: 495.02. Custom synthesis is available. Send your inquiries for more information. | London |
| Egg Yolk Lecithin | Egg Phosphatide Extract can be used to prevent and treat atherosclerosis. Group: Pharmaceutical. Alternative Names: Lipoid E 100; Lipoid E 75; Lipoid E 80; Lipoid E80S; Lipoid EPC; Nikkol Lecinol Y 10; Nikkol Lecinol Y 10E; Ovothin 120; Ovotin 160; PL 100; PL 100E; PL 100H; PL 100LE; PL 100M; PL 30S; PL 60; Phosphatides, egg yolk; Phospholipon E 80; QPFCPL 100P; Yokuretopauda LP; Yolk lecithin; Yolkin IP Lecithin; Phospholipids egg. CAS No. 93685-90-6. Pack Sizes: 100 g. Product ID: B1370-401932. Custom synthesis is available. Send your inquiries for more information. | London |
| Ehp-inhibitor-1 | Ehp-inhibitor-1 is an Eph family tyrosine kinase inhibitor targeting Eph receptors. Study indicated that inhibition of Eph receptors results in an increase in glucose-stimulated insulin secretion from mouse and human pancreatic islets. Group: Pharmaceutical. Alternative Names: 6-(3-methoxyphenyl)-3-pyridin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine. CAS No. 861249-59-4. Pack Sizes: 50 mg. Product ID: B0084-284759. Molecular formula: C18H15N5O. Mole weight: 317.352. Custom synthesis is available. Send your inquiries for more information. | London |
| Ehp-inhibitor-2 | Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors. Study indicated that inhibition of Eph receptors results in an increase in glucose-stimulated insulin secretion from mouse and human pancreatic islets. Group: Pharmaceutical. Alternative Names: 3-(7-amino-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenol. CAS No. 861249-77-6. Pack Sizes: 50 mg. Product ID: B0084-284760. Molecular formula: C17H13N5O. Mole weight: 303.325. Custom synthesis is available. Send your inquiries for more information. | London |
| EIDD-1931 | EIDD-1931 is a ribonucleoside analog that exhibits potential antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV. EIDD-1931 induces mutations in RNA virions, inhibiting SARS-CoV-2 and other coronavirus in mice and human airway epithelial cells. Group: Pharmaceutical. Alternative Names: N4-Hydroxycytidine; N(4)-Hydroxycytidine; Uridine, 4-oxime; Beta-D-N4-hydroxycytidine. CAS No. 3258-2-4. Pack Sizes: 50 mg. Product ID: B2693-338763. Molecular formula: C9H13N3O6. Mole weight: 259.22. Custom synthesis is available. Send your inquiries for more information. | London |
| EIDD-2801 | EIDD-2801, derived from N4-hydroxycytidine, is an oral bioavailable broad-spectrum antiviral compound that is effective against SARS-CoV2 infection. Uses: Antiviral agents. Group: Pharmaceutical. Alternative Names: Molnupiravir; EIDD 2801; EIDD2801; MK-4482; WHO 11853; N4-Hydroxycytidine, 5'-isopropyl ester; beta-D-N4 Hydroxycytidine-5'-isopropyl ester; Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-; EIDD 1931-isopropyl ester; Lagevrio; MK-4482; β-D-N4 hydroxycytidine-5'-isopropyl ester. CAS No. 2492423-29-5. Pack Sizes: 100 mg. Product ID: B2706-334395. Molecular formula: C13H19N3O7. Mole weight: 329.31. Custom synthesis is available. Send your inquiries for more information. | London |
| EIPA | EIPA is a TRPP3 channel inhibitor (IC50 = 10.5 μM). EIPA also acts as an Na+/H+ exchange inhibitor that suppresses the Na+/H+ exchanger (NHE). Uses: Epithelial sodium channel blockers. Group: Pharmaceutical. Alternative Names: Ethylisopropylamiloride; L 593754; MH 12-43; 3-Amino-N-(aminoiminomethyl)-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxamide. CAS No. 1154-25-2. Pack Sizes: 50 mg. Product ID: B2693-047130. Molecular formula: C11H18ClN7O. Mole weight: 299.76. Custom synthesis is available. Send your inquiries for more information. | London |
| EIPA hydrochloride | EIPA is a TRPP3 channel inhibitor (IC50 = 10.5 μM). EIPA also acts as an Na+/H+ exchange inhibitor that suppresses the Na+/H+ exchanger (NHE). Group: Pharmaceutical. Alternative Names: L593754 hydrochloride; L 593754 hydrochloride; L-593754 hydrochloride; Ethylisopropylamiloride hydrochloride; MH 12-43 hydrochloride; 3-Amino-N-(aminoiminomethyl)-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxamide hydrochloride. CAS No. 1345839-28-2. Pack Sizes: 250 mg. Product ID: B2693-334168. Molecular formula: C11H19Cl2N7O. Mole weight: 336.22. Custom synthesis is available. Send your inquiries for more information. | London |
| (E)-KPT330 | (E)-Kpt-330 is an E-isomer of Kpt-330, also known as Selinexor, which is an orally available inhibitor of CRM1 with potential antineoplastic activity. Group: Pharmaceutical. Alternative Names: (E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide; Selinexor trans-isomer; KPT-330, (E)-; UNII-MVY2AE6R24; MVY2AE6R24; KPT330,(E)-; 2-Propenoic acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-pyrazinyl)hydrazide, (2E)-; 1421923-86-5 (E-isomer); KPT330Selinexor; O=C(NNC1=NC=CN=C1)/C=C/N2N=C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)N=C2; 2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2E)-; (E)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide. CAS No. 1421923-86-5. Pack Sizes: 25 mg. Product ID: B0084-284796. Molecular formula: C17H11F6N7O. Mole weight: 443.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Elacestrant | Elacestrant, also referred to RAD1901, is a selective and orally available estrogen receptor (ERR) degrader (IC50= 48 and 870 nM for ERα and ERβ, respectively) and selective estrogen receptor modulator (SERM). Group: Pharmaceutical. Alternative Names: RAD1901; RAD-1901; RAD 1901. CAS No. 722533-56-4. Pack Sizes: 100 mg. Product ID: B1370-007281. Molecular formula: C30H38N2O2. Mole weight: 458.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Elacridar | Elacridar hydrochloride (GF120918A) is a P-glycoprotein inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog plasma. GF120918A did not demonstrate potent inhibition of several human cytochrome P450 enzymes evaluated in vitro, with IC(50) values well above concentrations anticipated to be achieved in vivo. Together, these data confirm the utility of GF120918A as a tool P-glycoprotein inhibitor in preclinical species and offer additional guidance on preclinical dose regimens likely to produce P-glycoprotein-mediated effects. Group: Pharmaceutical. Alternative Names: GF120918; GF-120918; GF 120918; GF-120918A; GF120918A; GF 120918A; GG 918; D03968. Elacridar hydrochloride. CAS No. 143664-11-3. Pack Sizes: 100 mg. Product ID: B0084-311800. Molecular formula: C34H33N3O5. Mole weight: 563.654. Custom synthesis is available. Send your inquiries for more information. | London |
| Elacridar hydrochloride | Elacridar is an orally bioavailable inhibitor of P-glycoprotein (P-gp) and ABCG2. Group: Pharmaceutical. Alternative Names: Elacridar HCl; N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide hydrochloride. CAS No. 143851-98-3. Pack Sizes: 50 mg. Product ID: B0084-458012. Molecular formula: C34H33N3O5.HCl. Mole weight: 600.1. Custom synthesis is available. Send your inquiries for more information. | London |
| Elafibranor | Elafibranor is a dual PPARα/δ agonist. Elafibranor increases plasma HDL and expression of Acox1, a PPARα target gene, and decreases plasma triglycerides and total cholesterol in the liver of ApoE2-KI wild-type mice. Elafibranor is identified as a drug candidate for the treatment of cardiometabolic diseases such as diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD). Group: Pharmaceutical. Alternative Names: Propanoic acid, 2-[2,6-dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methyl-; 2-[2,6-Dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methylpropanoic acid; (E)-1-[4-(Methylthio)phenyl]-3-[3,5-dimethyl-4-[(carboxydimethylmethyl)oxy]phenyl]prop-2-en-1-one; GFT 505; GFT-505; GFT505. CAS No. 923978-27-2. Pack Sizes: 250 mg. Product ID: B0084-074234. Molecular formula: C22H24O4S. Mole weight: 384.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Elagolix sodium | Elagolix is a selective gonadotropin-releasing hormone receptor (GnRHR) antagonist with KD of 54 pM. It is in phase III clinical trials for the treatment of endometriosis and uterine leiomyoma. Elagolix was also under investigation for the treatment of prostate cancer and benign prostatic hyperplasia, but development for these indications was ultimately not pursued. Uses: Endometriosis; uterine leiomyoma. Group: Pharmaceutical. Alternative Names: Sodium (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6H)-yl)-1-phenylethyl)amino)butanoate; NBI56418; NBI-56418; NBI 56418. CAS No. 832720-36-2. Pack Sizes: 25 mg. Product ID: B0084-354739. Molecular formula: C32H29F5N3NaO5. Mole weight: 653.58. Custom synthesis is available. Send your inquiries for more information. | London |
| Elbasvir | Elbasvir has been found to restrain viral phosphoprotein so that could be used against hepatitis C virus and is currently under Phase II trail. Uses: Elbasvir has been found to restrain viral phosphoprotein so that could be used against hepatitis c virus and is currently under phase ii trail. Group: Pharmaceutical. Alternative Names: Elbasvir; MK-8742; UNII-632L571YDK; 632L571YDK; MK8742; MK 8742. CAS No. 1370468-36-2. Pack Sizes: 100 mg. Product ID: B0084-474522. Molecular formula: C49H55N9O7. Mole weight: 882.02. Custom synthesis is available. Send your inquiries for more information. | London |
| Eldecalcitol | Eldecalcitol, a vitamin D analog, has strong effects to reduce calcium reabsorption into the body from bones, therefore increasing bone mineral density, and to increase calcium absorption in intestines. Group: Pharmaceutical. Alternative Names: Edirol; ED-71; 2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3; 2-(3-Hydroxypropoxy)calcitriol; 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3. CAS No. 104121-92-8. Pack Sizes: 1 mg. Product ID: B0084-305756. Molecular formula: C30H50O5. Mole weight: 490.72. Custom synthesis is available. Send your inquiries for more information. | London |
| Eldecalcitol Intermediate A | Eldecalcitol Intermediate A is an intermediate of eldecalcitol, a vitamin D3 analogue for the treatment of osteoporosis. Eldecalcitol is more active in bone resorption inhibition in comparison with alfacalcidol. Group: Pharmaceutical. Alternative Names: 3-[(1R,2R,4Z,6R)-2,6-bis[[tert-butyl(dimethyl)silyl]oxy]-4-(2-diphenylphosphorylethylidene)-3-methylidenecyclohexyl]oxypropoxy-tert-butyl-dimethylsilane. CAS No. 200636-54-0. Pack Sizes: 1 mg. Product ID: B1960-112373. Molecular formula: C42H71O5PSi3. Mole weight: 771.25. Custom synthesis is available. Send your inquiries for more information. | London |
| Eldecalcitol Intermediate CD | Eldecalcitol Intermediate CD is a vital component used in the compound industry. Specifically designed for pharmaceutical applications, this intermediate plays a crucial role in the synthesis of Eldecalcitol, a drug used for the research of osteoporosand other bone-related disorders. Group: Pharmaceutical. Alternative Names: ED71-CD ring; 25-[(triethylsilyl)oxy]de-A,B-cholestan-8-one; (1R,3aR,7aR)-7a-Methyl-1-((R)-6-methyl-6-((triethylsilyl)oxy)heptan-2-yl)hexahydro-1H-inden-4(2H)-one. CAS No. 144848-24-8. Pack Sizes: 10 mg. Product ID: B1960-112375. Molecular formula: C24H46O2Si. Mole weight: 394.71. Custom synthesis is available. Send your inquiries for more information. | London |
| Eleclazine | Eleclazine is a selective Sodium channel antagonist. Eleclazin showed a shortening of the QTc interval (the time interval between the start of the Q-wave and end of the T-wave in the heart's electrical cycle) in patients with long QT-3 (LQT3) syndrome. Phase III clinical trilas for the treatment of Long QT syndrome, Phase II/III clinical trilas for the treatment of Hypertrophic cardiomyopathy and Phase II clinical trilas for the treatment of Ventricular arrhythmias are on-going. Uses: Long qt syndrome;hypertrophic cardiomyopathy;ventricular arrhythmias. Group: Pharmaceutical. Alternative Names: GS-6615; GS 6615; GS6615; Eleclazine. 4-[(pyrimidin-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]- 3,4-dihydro-1,4-benzoxazepin-5(2H)-one. CAS No. 1443211-72-0. Pack Sizes: 50 mg. Product ID: B2693-475446. Molecular formula: C21H16F3N3O3. Mole weight: 415.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Elesclomol | Elesclomol is a HSP-90 Inhibitor, and is a small-molecule bis(thio-hydrazide amide) with oxidative stress induction, pro-apoptotic, and potential antineoplastic activities. Elesclomol induces oxidative stress, creating high levels of reactive oxygen species (ROS), such as hydrogen peroxide, in both cancer cells and normal cells. Because tumor cells have elevated levels of ROS compared to normal cells, the increase in oxidative stress beyond baseline levels elevates ROS beyond sustainable levels, exhausting tumor cell antioxidant capacity, which may result in the induction of the mitochondrial apoptosis pathway. Normal cells are spared because the increase in the level of oxidative stress induced by this agent is below the threshold at which apoptosis is induced. Elesclomol is currently developed by Synta Pharmaceuticals Corp. Group: Pharmaceutical. Alternative Names: STA4783; STA-4783; STA 4783, Elesclomol. CAS No. 488832-69-5. Pack Sizes: 25 mg. Product ID: B0084-212109. Molecular formula: C19H20N4O2S2. Mole weight: 400.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Eleutheroside A | Daucosterol can be used as an efficient and inexpensive neuroprotectant, to which the IGF1-like activity of Daucosterol contributes. Daucosterol could be potentially developed as a medicine for ischemic stroke treatment. Uses: Analgesic. Group: Pharmaceutical. Alternative Names: Daucosterol; Sitogluside; Alexandrin; beta-Sitosterol glucoside; Daucosterin; Coriandrinol. CAS No. 474-58-8. Pack Sizes: 20 mg. Product ID: NP6068. Molecular formula: C35H60O6. Mole weight: 576.85. Custom synthesis is available. Send your inquiries for more information. | London |
| Eleutheroside B1 | Eleutheroside B1 is a coumarin with anti-human influenza virus efficacy. Group: Pharmaceutical. Alternative Names: Isofraxidin-7-O-a-D-glucoside. CAS No. 16845-16-2. Pack Sizes: 10 mg. Product ID: B2703-334415. Molecular formula: C17H20O10. Mole weight: 384.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Eleutheroside C | Eleutheroside C is isolated from the root barks of Eleutherococcus senticosus. Group: Pharmaceutical. Alternative Names: ethyl alpha-d-galactopyranoside. CAS No. 15486-24-5. Pack Sizes: 5 mg. Product ID: NP4234. Molecular formula: C8H16O6. Mole weight: 208.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Elexacaftor | Elexacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector used as a medication for cystic fibrosis treatment in combination with ivacaftor and tezacaftor. Group: Pharmaceutical. Alternative Names: VX-445; VX445; (S)-N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide. CAS No. 2216712-66-0. Pack Sizes: 25 mg. Product ID: B1370-381497. Molecular formula: C26H34F3N7O4S. Mole weight: 597.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Eliglustat hemitartrate | Eliglustat hemitartrate is a specific inhibitor of glucosylceramide synthase. It is under development as an oral substrate reduction therapy for Gaucher disease type 1 (GD1). It was developed by Genzyme Corp and has been listed by the FDA August 2014. Group: Pharmaceutical. Alternative Names: Genz-112638; Genz 112638; Genz112638; Eliglustat tartrate; Bis(N-((1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(pyrrolidin-1- ylmethyl)ethyl)octanamide) (2R,3R)-2,3-dihydroxybutanedioate; Octanamide, N-((1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1- pyrrolidinylmethyl)ethyl)-, (2R,3R)-2,3-dihydroxybutanedioate; N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide (2R,3R)-2,3-dihydroxybutanedioic acid. CAS No. 928659-70-5. Pack Sizes: 1 g. Product ID: B2693-474918. Molecular formula: C50H78N4O14. Mole weight: 959.17. Custom synthesis is available. Send your inquiries for more information. | London |
| Eliprodil | Eliprodil, a NR2B-NMDA receptor antagonist, was found to have neuroprotective activity in study of ischemia. Uses: Eliprodil is a nr2b-nmda receptor antagonist that was found to have neuroprotective activity in study of ischemia. Group: Pharmaceutical. Alternative Names: -(4-Chlorophenyl)-4-[(4-fluorophenyl)methyl]-1-piperidineethanol, SL-82,0715; SL82,0715; SL 82,0715; SL-820715; SL820715; SL 820715; Eliprodil. CAS No. 119431-25-3. Pack Sizes: 50 mg. Product ID: B0084-359860. Molecular formula: C20H23ClFNO. Mole weight: 347.85. Custom synthesis is available. Send your inquiries for more information. | London |
| Ellagic acid | Ellagic acid is a natural phenol antioxidant found in numerous fruits and vegetables. The antiproliferative and antioxidant properties of ellagic acid have prompted research into its potential health benefits. It has been fraudulently marketed as having the ability to prevent and treat a number of human maladies, including cancer, but such claims have not been proven. Ellagic acid can be used in cosmetics material. Uses: Anti-proliferative; anti-oxidant. Group: Pharmaceutical. Alternative Names: Elagostasine, Gallogen; Alizarine Yellow; Benzoaric acid; CCRIS 774; CCRIS774; CCRIS-774; HSDB 7574; HSDB7574; HSDB-7574; Lagistase. CAS No. 476-66-4. Pack Sizes: 100 g. Product ID: NP5371. Molecular formula: C14H6O8. Mole weight: 302.19. Custom synthesis is available. Send your inquiries for more information. | London |
| ELOVL1-IN-2 | ELOVL1-IN-2 is an inhibitor of ELOVL1 (elongation of very-long-chain-fatty acid 1). Group: Pharmaceutical. CAS No. 2761063-79-8. Pack Sizes: 50 mg. Product ID: B1370-149624. Molecular formula: C18H15FN2O. Mole weight: 294.3. Custom synthesis is available. Send your inquiries for more information. | London |
| ELQ-300 | ELQ-300 is a potent and orally bioavailable antimalarial agent, and it is a novel inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (complex III in the electron transport chain). Group: Pharmaceutical. Alternative Names: ELQ300; ELQ 300; 6-Chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-one. CAS No. 1354745-52-0. Pack Sizes: 50 mg. Product ID: B1370-334059. Molecular formula: C24H17ClF3NO4. Mole weight: 475.84. Custom synthesis is available. Send your inquiries for more information. | London |
| Elsinochrome A | It is produced by the strain of Elsinoe annonae, Sphaceloma randii. It's the same as Hypericin, it has photodynamic activity and inhibits protein kinase C activity. Group: Pharmaceutical. Alternative Names: (1r,2r)-1,2-diacetyl-4,11-dihydroxy-3,7,8,12-tetramethoxy-1,2-dihydrobenzo[ghi]perylene-5,10-dione; 1alpha,2beta-Diacetyl-1,2-dihydro-5,10-dihydroxy-3,7,8,12-tetramethoxybenzo[ghi]perylene-4,11-dione; Benzo(ghi)perylene-4,11-dione, 1,2-diacetyl-1,2-dihydro-5,10-dihydroxy-3,7,8,12-tetramethoxy-, trans-. CAS No. 24568-67-0. Pack Sizes: 1mg;1g;10g. Product ID: BBF-01206. Molecular formula: C30H24O10. Mole weight: 544.51. Custom synthesis is available. Send your inquiries for more information. | London |
| Eltenac | Eltenac is a non-steroidal anti-inflammatory drug (NSAID). Group: Pharmaceutical. Alternative Names: 2-[4-(2,6-dichloroanilino)thiophen-3-yl]acetic acid. CAS No. 72895-88-6. Pack Sizes: 1mg;1g;10g. Product ID: 72895-88-6. Molecular formula: C12H9Cl2NO2S. Mole weight: 302.169. Custom synthesis is available. Send your inquiries for more information. | London |
| Eltoprazine dihydrochloride | Eltoprazine dihydrochloride is a drug that had previously been developed for aggression, has recently been investigated for L-DOPA-induced dyskinesia in animal models of Parkinson's disease (PD) and in dyskinetic PD patients. Group: Pharmaceutical. Alternative Names: Eltoprazine (dihydrochloride). CAS No. 143485-51-2. Pack Sizes: 1mg;1g;10g. Product ID: 143485-51-2. Molecular formula: C12H18Cl2N2O2. Mole weight: 293.19. Custom synthesis is available. Send your inquiries for more information. | London |
| Eltoprazine hydrochloride | Eltoprazine hydrochloride is the hydrochloride form of Eltoprazine which is a serenic or antiaggressive agent. It acts as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor with Ki values of 40, 52 and 81 nM for 5-HT1A, 5-HT1B and 5-HT2C receptors respectively. It has been shown to reduce L-DOPA-induced dyskinesias in experimental models of Parkinson's Disease and in human patients, although this effect was accompanied by a partial worsening of the therapeutic effect of l-dopa in vivo. It is used as a novel drug for the treatment of anxiety as well as other neurological and mental disorders. It was developed by PsychoGenics and Amarantus Bioscience, Inc. It is in clinical stage 3. Uses: Eltoprazine hydrochloride has been shown to reduce l-dopa-induced dyskinesias in experimental models of parkinson's disease and in human patients. it is used as a novel drug for the treatment of anxiety as well as other neurological and mental disorders. Group: Pharmaceutical. Alternative Names: Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-, monohydrochloride;1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine hydrochloride;DU-28853 hydrochloride;DU28853 hydrochloride. CAS No. 98206-09-8. Pack Sizes: 50 mg. Product ID: B2693-261153. Molecular formula: C12H17N2O2Cl. Mole weight: 256.73. Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.